Hunter Holmes Mcguire Veteran Affairs Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Hunter Holmes Mcguire Veteran Affairs Medical Center sits in the top decile of US sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count).

27 total trials 3 currently recruiting 23 completed early-phase tilt top decile by trial count

Hunter Holmes Mcguire Veteran Affairs Medical Center: 27 sponsored US clinical trials, 3 recruiting.

Hunter Holmes Mcguire Veteran Affairs Medical Center sponsors 27 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 23 completed. 1 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cirrhosis, with 3 trials.

Top-decile sponsor footprint

Hunter Holmes Mcguire Veteran Affairs Medical Center ranks in the top decile of sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

23 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

27 total, page 1 of 1

RECRUITING NA

Microbiome Modulation With Prebiotics in PTSD and Cirrhosis

NCT06464952

RECRUITING Phase 2

Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

NCT06052176

RECRUITING

Oral Health In Cirrhosis of the Liver (ORACLE)

NCT06052150

ACTIVE NOT RECRUITING Phase 1

Cryotherapy for Locally Advanced Esophageal Cancer

NCT04248582

COMPLETED

Longitudinal Monitoring of Stool Characteristics

NCT05604274

COMPLETED NA

Longitudinal Monitoring of Inflammation in Cirrhosis

NCT05538962

COMPLETED NA

Effect of Brief Dietary Intervention on Ammonia Levels

NCT05376488

COMPLETED NA

Feasibility and Efficacy of A Yoga Intervention for Comorbid Chronic Pain and PTSD

NCT06123065

COMPLETED NA

Low Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) for Erectile Dysfunction

NCT04720755

COMPLETED Phase 1

Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation

NCT04357782

COMPLETED Phase 2

Rifamycin in Minimal Hepatic Encephalopathy

NCT04082780

COMPLETED Phase 2

HEAL STUDY (Hepatic Encephalopathy and Albumin Study)

NCT03585257

COMPLETED Phase 1

Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis

NCT03416751

COMPLETED NA

rTMS for Cognitive Rehabilitation After TBI

NCT03642158

COMPLETED NA

Postoperative Peripheral Nerve Stimulation for Management of Post-amputation Pain

NCT03484429

COMPLETED NA

Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting

NCT03662529

COMPLETED NA

Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis

NCT02944643

COMPLETED NA

Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer

NCT02606396

COMPLETED Early Phase 1

Pilot Synovial Fluid Molecular/Stem Cell Response to PRP in Knee Osteoarthritis: Clinical & Imaging Outcome Correlation

NCT02468492

COMPLETED NA

iPod Games in Hepatic Encephalopathy

NCT02154282

COMPLETED NA

Proton Pump Inhibitors and Dysbiosis in Cirrhosis

NCT01458990

COMPLETED Phase 3

Effect of Tolvaptan on Cognitive Function in Cirrhosis

NCT01556646

COMPLETED Phase 1

Study of Rifaximin in Minimal Hepatic Encephalopathy

NCT01069133

COMPLETED NA

A Study of Controlled Lactulose Withdrawal

NCT00914056

COMPLETED NA

Rifaximin in Minimal Hepatic Encephalopathy

NCT00533910

COMPLETED

Bassini Inguinal Hernia Repair: Obsolete Or Still A Viable Surgical Option?

NCT04888078

COMPLETED

The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections

NCT00448942

What is open in the Hunter Holmes Mcguire Veteran Affairs Medical Center pipeline

3 recruiting of 27 indexed (11% open); 23 completed (85%).

Phase mix: 1 late (III/IV) vs 8 early (I/II) (early-phase heavy).

Top condition: Cirrhosis (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Hunter Holmes Mcguire Veteran Affairs Medical Center: open-pipeline peers nationwide

Peers matched on 27 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Hunter Holmes Mcguire Veteran Affairs Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%5%10%15%20% Total trials Recruiting share Hunter Holmes Mcguire Veteran Affairs Medical CenterAkron Children's HospitalArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)AVEO PharmaceuticalsDompé Farmaceutici S.p.AADC Therapeutics S.A.Adrian VellaAIDS Malignancy ConsortiumAmylyx Pharmaceuticals
Hunter Holmes Mcguire Veteran Affairs Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Hunter Holmes Mcguire Veteran Affairs Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 27 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this Hunter Holmes Mcguire Veteran Affairs Medical Center page

27 registered trials is a research-attention snapshot, not an endorsement of Hunter Holmes Mcguire Veteran Affairs Medical Center or any single study.

  • 3 of Hunter Holmes Mcguire Veteran Affairs Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cirrhosis is the condition Hunter Holmes Mcguire Veteran Affairs Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cirrhosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Hunter Holmes Mcguire Veteran Affairs Medical Center pipeline card: 27 registered trials from official public datasets.Report a data error.